# Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD

> **NCT07313007** · NA · NOT_YET_RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 24 (estimated)

## Conditions studied

- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- Metabolic Dysfunction-Associated Steatohepatitis (MASH)

## Interventions

- **PROCEDURE:** stool sampling, dietary assessment, and collection of blood and urine samples

## Key facts

- **NCT ID:** NCT07313007
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313007, "Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07313007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*